How can industry better support National Healthcare Systems
BOOK YOUR PLACE NOW!
Quality by Design (QbD) is a science and risk-based approach to the development and manufacture of medicines and healthcare products that enable cost effective delivery of products over their lifecycle.
This event brings together leading industry experts, regulators and academics, to share best practice and research aligned to the QbD agenda, as well as to discuss progress in ‘real life’ QbD implementation.
Presentations will include; Digital Transformation, New Technologies, Artificial Intelligence, and re-thinking the way the Pharma Industry operates, and the exhibition hall will provide the right environment for discussion with experts from industry.
Keynote Speaker: Dr Line Lundsberg
Line runs her own consultancy business, Lundsberg Consulting Ltd, supporting clients in developing and manufacturing pharmaceutical products, and has a role as Global Technology Partner within NNE, a global pharma engineering company.
Line has spent more than 20 years in the Pharmaceutical Industry (API & Drug Product Development and Manufacturing) and is specialised in the science and risk-based concept of Pharmaceutical Development and Manufacturing including; Quality by Design (QbD), Process Analytical Technology (PAT), Process Validation lifecycle (PV), Good Manufacturing Practise (GMP), Quality Risk Management (QRM), Pharma 4.0 and the related regulatory and compliance aspects.
FULL PROGRAMME INFORMATION
Other confirmed speakers:
Dr Walkiria Schlindwein - Associate Professor of Pharmaceutics at Leicester School of Pharmacy
Professor Dana Brown - Pro Vice-Chancellor/Dean, Faculty of Business and Law and Principal, Leicester Castle Business School
Dr Indra Joshi - Digital Health and AI Clinical Lead (NHS England)
Professor Kendall Pitt - Senior Technical Director in Global Manufacturing and Supply for GlaxoSmithKline
Professor Melissa Hanna-Brown - Associate Research Fellow, Pfizer UK
Dr Andrea Johnston - CMAC EPSRC Centre Manager
Dr Alastair Coupe - Senior Director, Drug Product Design, Pharmaceutical Sciences, Pfizer Ltd, Sandwich UK
Dr Helen Muirhead - Senior Vice President Respiratory Medicines at GMPharma Limited
Professor Mike Hannay - Managing Director East Midlands Academic health Science Network (EMAHSN) and Chair of the AHSN Network
Professor Gordon Muirhead - President of GMPharma Limited, a Pharmaceutical Consultancy
For more information visit www.qbd.dmu.ac.uk/symposium